News
Events
Overview
Rationale for Immunodrugs™
Strategy
Board & Management
Industry Collaborations
Letter of the CEO
History
Overview
Immunodrug™ Platform
Immunodrug™ Manufacturing
Scientific Collaborations
Scientific Publications
Pipeline
Clinical Trials
Disease Areas
Overview
Board & Management
Share Information
Bond Information
Analyst Coverage
Financial Calendar
Financial Reports
Corporate Governance
Stay Informed
Contact
Overview
Press Release Archive
Downloads
Picture Gallery
Contact
News &
Events
Corporate
Overview
Science &
Technology
R & D
Pipeline
Partnering
Investor
Relations
Media
Careers &
Jobs
Share
Information
Home
Contact
Directions
Glossary
Site Map
Disclaimer
Cytos
Press Releases
Cytos
Facts & Figures
Cytos Biotechnology AG
Wagistrasse 25
Postfach
8952 Schlieren
Switzerland
T +41 44 733 47 47
F +41 44 733 47 40
e-mail
contact
SIX:CYTN Cytos Biotechnology Ltd
ISIN: CH0011025217
Swiss Security Number: 1,102,521
Common Code: 015626003
Share information
The share capital of Cytos is CHF 526,137.50 fully paid up and divided into 5,261,375 registered shares with a nominal value of CHF 0.10 each according to the Commercial Register of the Canton of Zurich.
